Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease

Identifieur interne : 002811 ( Main/Exploration ); précédent : 002810; suivant : 002812

Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease

Auteurs : J. Eric Ahlskog [États-Unis] ; Gertrude M. Tyce [États-Unis] ; Patrick J. Kelly [États-Unis] ; Jon A. Van Heerden [États-Unis] ; Susan L. Stoddard [États-Unis] ; Stephen W. Carmichael [États-Unis]

Source :

RBID : ISTEX:A9C4C1EB70B6ED82192BEF7B92A9D45C73558F7D

Abstract

Cerebrospinal fluid (CSF) and serum or plasma concentrations of albumin, IgG and carbidopa were measured before and after adrenal-brain transplantation in patients with Parkinson's disease to indirectly assess blood-brain barrier (BBB) integrity. Previous studies in animals have suggested that the BBB is compromised by cerebral transplantation. CSF and plasma levodopa was also measured to permit comparison with the carbidopa values, recognizing that levodopa readily crosses the BBB via facilitated transport. Our patients underwent adrenal-brain transplantation in accordance with the method of Madrazo et al. (I. Madrazo, R. Drucker-Colin, V. Diaz, J. Martinez-Mata, C. Torres, and J. J. Becerril, 1987, N. Engl. J. Med. 316: 831–834) in which adrenal medullary pieces are implanted in the head of the caudate nucleus, in contact with the cerebrospinal fluid. All patients were maintained on oral carbidopa/levodopa therapy after surgery. CSF albumin/serum albumin and CSF IgG/serum IgG ratios were initially elevated above the preoperative baseline 6 weeks after the surgery; however, these values returned to the preoperative baseline by 6 months following the operation in six of seven patients. This suggested that the BBB was sufficiently intact to exclude these larger protein molecules from the CSF of these six patients. On the other hand, exogenously administered carbidopa, which normally is largely excluded from the cerebrospinal fluid by the BBB, was modestly increased in the CSF in four of the five patients in which it was measured. This suggests that the transplant BBB might be partially patent to small molecules for at least 6 months after the surgery. Whether increased passage of carbidopa into CSF and perhaps the transplant is of clinical significance has yet to be determined. Median CSF levodopa did not increase after surgery, probably because a limited defect in the BBB would be likely to be overshadowed by the effects of facilitated transport. CT scans performed following intravenous iothalamate meglumine contrast failed to reveal enhancement (dye leakage) near the transplantation site; however, artifact from the metal surgical clips used in the Madrazo procedure prevented good visualization of the area.

Url:
DOI: 10.1016/0014-4886(89)90114-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease</title>
<author>
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
</author>
<author>
<name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name>
</author>
<author>
<name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name>
</author>
<author>
<name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name>
</author>
<author>
<name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name>
</author>
<author>
<name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A9C4C1EB70B6ED82192BEF7B92A9D45C73558F7D</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1016/0014-4886(89)90114-3</idno>
<idno type="url">https://api.istex.fr/document/A9C4C1EB70B6ED82192BEF7B92A9D45C73558F7D/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001925</idno>
<idno type="wicri:Area/Main/Curation">001677</idno>
<idno type="wicri:Area/Main/Exploration">002811</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease</title>
<author>
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Neurology, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Physiology and Biophysics, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Neurosurgery, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Surgery, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Department of Anatomy, Indiana University School of Medicine, Fort Wayne</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Anatomy, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Experimental Neurology</title>
<title level="j" type="abbrev">YEXNR</title>
<idno type="ISSN">0014-4886</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1989">1989</date>
<biblScope unit="volume">105</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="152">152</biblScope>
<biblScope unit="page" to="161">161</biblScope>
</imprint>
<idno type="ISSN">0014-4886</idno>
</series>
<idno type="istex">A9C4C1EB70B6ED82192BEF7B92A9D45C73558F7D</idno>
<idno type="DOI">10.1016/0014-4886(89)90114-3</idno>
<idno type="PII">0014-4886(89)90114-3</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0014-4886</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cerebrospinal fluid (CSF) and serum or plasma concentrations of albumin, IgG and carbidopa were measured before and after adrenal-brain transplantation in patients with Parkinson's disease to indirectly assess blood-brain barrier (BBB) integrity. Previous studies in animals have suggested that the BBB is compromised by cerebral transplantation. CSF and plasma levodopa was also measured to permit comparison with the carbidopa values, recognizing that levodopa readily crosses the BBB via facilitated transport. Our patients underwent adrenal-brain transplantation in accordance with the method of Madrazo et al. (I. Madrazo, R. Drucker-Colin, V. Diaz, J. Martinez-Mata, C. Torres, and J. J. Becerril, 1987, N. Engl. J. Med. 316: 831–834) in which adrenal medullary pieces are implanted in the head of the caudate nucleus, in contact with the cerebrospinal fluid. All patients were maintained on oral carbidopa/levodopa therapy after surgery. CSF albumin/serum albumin and CSF IgG/serum IgG ratios were initially elevated above the preoperative baseline 6 weeks after the surgery; however, these values returned to the preoperative baseline by 6 months following the operation in six of seven patients. This suggested that the BBB was sufficiently intact to exclude these larger protein molecules from the CSF of these six patients. On the other hand, exogenously administered carbidopa, which normally is largely excluded from the cerebrospinal fluid by the BBB, was modestly increased in the CSF in four of the five patients in which it was measured. This suggests that the transplant BBB might be partially patent to small molecules for at least 6 months after the surgery. Whether increased passage of carbidopa into CSF and perhaps the transplant is of clinical significance has yet to be determined. Median CSF levodopa did not increase after surgery, probably because a limited defect in the BBB would be likely to be overshadowed by the effects of facilitated transport. CT scans performed following intravenous iothalamate meglumine contrast failed to reveal enhancement (dye leakage) near the transplantation site; however, artifact from the metal surgical clips used in the Madrazo procedure prevented good visualization of the area.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Indiana</li>
<li>Minnesota</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
</region>
<name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name>
<name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name>
<name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name>
<name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name>
<name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002811 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002811 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A9C4C1EB70B6ED82192BEF7B92A9D45C73558F7D
   |texte=   Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024